🔬 Health & Fitness Research
Abbott’s Libre Duo won FDA clearance for glucose and ketone monitoring on a single patch, aimed at early DKA detection for closed-loop insulin pump users. Shipping timeline and pump integrations remain unconfirmed, so nobody can upgrade to it yet.
Marty’s Take:
Automated insulin delivery loops only work as well as the data feeding them, and ketone visibility closes a real gap. When someone’s on the fence between closed-loop systems, sensor accuracy and integration breadth belong at the top of the checklist, not battery life or app polish. Worth cross-referencing against our best fitness tracker roundup before betting on any platform.
Source: MedTech Dive

